1-3 of 3
Pedro Gascon
Close
Sort by
Journal Articles

A Comparison of Proposed Biosimilar and Originator Filgrastim for the Prevention of Neutropenia in Patients with Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Phase III, Randomized, Double-Blind Trial (The PIONEER study)

Kimberly Blackwell, Vladimir Semiglazov, Pedro Gascon, Roumen Nakov, Stefan Kramer, Arnd Schwebig, MD, Nadia Harbeck
Journal: Blood
Blood (2014) 124 (21): 5133.
https://doi.org/10.1182/blood.V124.21.5133.5133
Published: 2014
Journal Articles

Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study

Deval D. Joshi, Anju Dang, Prem Yadav, Jing Qian, Persis S. Bandari, Kunhua Chen, Robert Donnelly, Tammy Castro, Pedro Gascon, Ali Haider, Pranela Rameshwar
Journal: Blood
Blood (2001) 98 (9): 2697–2706.
https://doi.org/10.1182/blood.V98.9.2697
Published: 2001
Journal Articles

Mimicry between neurokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosis

Pranela Rameshwar, Deval D. Joshi, Prem Yadav, Jing Qian, Pedro Gascon, Victor T. Chang, Devashish Anjaria, Jonathan S. Harrison, Xiaosong Song
Journal: Blood
Blood (2001) 97 (10): 3025–3031.
https://doi.org/10.1182/blood.V97.10.3025
Published: 2001